DE69808839D1 - Makrophagen-stimulierende Protein für Behandlung von Erkrankungen des Nervensystems - Google Patents
Makrophagen-stimulierende Protein für Behandlung von Erkrankungen des NervensystemsInfo
- Publication number
- DE69808839D1 DE69808839D1 DE69808839T DE69808839T DE69808839D1 DE 69808839 D1 DE69808839 D1 DE 69808839D1 DE 69808839 T DE69808839 T DE 69808839T DE 69808839 T DE69808839 T DE 69808839T DE 69808839 D1 DE69808839 D1 DE 69808839D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- nervous system
- macrophage
- diseases
- stimulating protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001247A IT1292017B1 (it) | 1997-05-28 | 1997-05-28 | Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69808839D1 true DE69808839D1 (de) | 2002-11-28 |
DE69808839T2 DE69808839T2 (de) | 2003-09-18 |
Family
ID=11377233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69808839T Expired - Lifetime DE69808839T2 (de) | 1997-05-28 | 1998-05-26 | Makrophagen-stimulierende Protein für Behandlung von Erkrankungen des Nervensystems |
Country Status (8)
Country | Link |
---|---|
US (1) | US6030949A (de) |
EP (1) | EP0880971B1 (de) |
AT (1) | ATE226445T1 (de) |
DE (1) | DE69808839T2 (de) |
DK (1) | DK0880971T3 (de) |
ES (1) | ES2185083T3 (de) |
IT (1) | IT1292017B1 (de) |
PT (1) | PT880971E (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002258798A1 (en) * | 2001-04-13 | 2002-10-28 | Children's Hospital Medical Center | Methods for the treatment of hepatic disorders |
AU2003280130B2 (en) | 2002-06-28 | 2009-06-11 | Centocor, Inc. | Mammalian CH1 deleted mimetibodies, compositions, methods and uses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082670A (en) * | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
US5696086A (en) * | 1994-11-03 | 1997-12-09 | Genentech, Inc. | Methods and kits using macrophage stimulating protein |
JPH093099A (ja) * | 1995-06-20 | 1997-01-07 | Toyobo Co Ltd | マクロファージ刺激蛋白質改変体およびその製造法 |
-
1997
- 1997-05-28 IT IT97MI001247A patent/IT1292017B1/it active IP Right Grant
-
1998
- 1998-05-26 US US09/084,233 patent/US6030949A/en not_active Expired - Lifetime
- 1998-05-26 PT PT98109508T patent/PT880971E/pt unknown
- 1998-05-26 DK DK98109508T patent/DK0880971T3/da active
- 1998-05-26 EP EP98109508A patent/EP0880971B1/de not_active Expired - Lifetime
- 1998-05-26 ES ES98109508T patent/ES2185083T3/es not_active Expired - Lifetime
- 1998-05-26 DE DE69808839T patent/DE69808839T2/de not_active Expired - Lifetime
- 1998-05-26 AT AT98109508T patent/ATE226445T1/de active
Also Published As
Publication number | Publication date |
---|---|
ES2185083T3 (es) | 2003-04-16 |
ITMI971247A1 (it) | 1998-11-28 |
DE69808839T2 (de) | 2003-09-18 |
EP0880971B1 (de) | 2002-10-23 |
US6030949A (en) | 2000-02-29 |
DK0880971T3 (da) | 2003-02-24 |
PT880971E (pt) | 2003-02-28 |
IT1292017B1 (it) | 1999-01-25 |
ATE226445T1 (de) | 2002-11-15 |
EP0880971A2 (de) | 1998-12-02 |
ITMI971247A0 (de) | 1997-05-28 |
EP0880971A3 (de) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927823D1 (de) | Hydrogel für die therapeutische behandlung von aneurysmas | |
DE69822665D1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
NO307968B1 (no) | Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav | |
ME00513B (me) | Azabicikloalkani kao modulatori ccr5 | |
DE69600307D1 (de) | Beatmungsgerät zur Behandlung von Ateminsuffizienzen | |
EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
DE60023043D1 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
ATA76995A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen | |
DE69106586T2 (de) | Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris. | |
DE60231107D1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DE69807466T2 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
DE69808839D1 (de) | Makrophagen-stimulierende Protein für Behandlung von Erkrankungen des Nervensystems | |
DE60043648D1 (de) | Medikamente zur behandlung von periodontalen erkrankungen | |
HUP0002377A2 (hu) | Melatoninerg ligandumok alkalmazása gyomor-bélrendszeri betegségek kezelésére vagy megelőzésére alkalmas gyógyászati készítmények előállítására és a készítmények | |
DE69806062T2 (de) | Kombinationstherapie zur behandlung von aids | |
DE69813354T2 (de) | Mittel zur Behandlung von Herzkrankheiten | |
ATE203680T1 (de) | Konjugat zur behandlung von entzündungserkrankungen | |
NO982151D0 (no) | Hemoregulatoriske forbindelser | |
HUP0100639A1 (hu) | Humán alfa1-savas glikoprotein alkalmazása gyógyszerkészítmények előállítására | |
ATE92763T1 (de) | Mittel zur behandlung des parkinson-syndroms. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: DOMPE' PHA.R.MA S.P.A., L'AQUILA, IT |